What is Fragile X syndrome? “Fragile X Syndrome (FXS) is the most common inherited cause of learning disability,” says Richardson. “The condition affects approximately one in 4,000 males and ...

According to new research announced today, the fragile X syndrome (FXS) market across the USA and Germany is projected to ...

US-based biopharmaceutical company Spinogenix has published top line outcomes from a Phase II trial of SPG601 for treating ...

A growth occurring in the next five years will be fuelled by the launch of two high-priced pipeline products providing ...

This study is a major step toward the ultimate goal of treating fragile X syndrome (FXS), an inherited form of mental retardation and the predominant monogenetic cause of autism. The study is also ...

The FREE methylation test has been closely related to FMR1 protein expression and identified fragile X syndrome (FXS)-affected males and females with 100% specificity in our small study (75 male ...

Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and Memory reports a new way to treat pathology and symptoms of fragile X syndrome, ...

Scheduled Feeding improved sleep/wake rhythms in the Fmr1 KO mutants.

The drug is also being evaluated for Fragile X syndrome (FXS), the leading cause of inherited intellectual disabilities, 3 in a pivotal Phase 2b/3 program in the U.S. Jordan’s Guardian Angels ...

MIT researchers suggests a potential molecular strategy for treating fragile X syndrome by enhancing NMDA subunit function.

Autism-Misregulated eIF4G Microexons Control Synaptic Translation and Higher Order Cognitive Functions. Gonatopoulos-Pournatzis T, Niibori R, Salter EW, Weatheritt RJ, Tsang B, Farhangmehr S ...

US-based biopharmaceutical company Spinogenix has published top line outcomes from a Phase II trial of SPG601 for treating Fragile X syndrome (FXS), a genetic disorder linked to autism and ...